Pleiotropy, epistasis and the genetic architecture of quantitative traits

TFC Mackay, RRH Anholt - Nature Reviews Genetics, 2024 - nature.com
Pleiotropy (whereby one genetic polymorphism affects multiple traits) and epistasis
(whereby non-linear interactions between genetic polymorphisms affect the same trait) are …

NGLY1 deficiency, a congenital disorder of deglycosylation: from disease gene function to pathophysiology

A Pandey, JM Adams, SY Han, H Jafar-Nejad - Cells, 2022 - mdpi.com
N-Glycanase 1 (NGLY1) is a cytosolic enzyme involved in removing N-linked glycans of
misfolded N-glycoproteins and is considered to be a component of endoplasmic reticulum …

Ferroptosis regulation by the NGLY1/NFE2L1 pathway

GC Forcina, L Pope, M Murray… - Proceedings of the …, 2022 - National Acad Sciences
Ferroptosis is an oxidative form of nonapoptotic cell death whose transcriptional regulation
is poorly understood. Cap'n'collar (CNC) transcription factors including nuclear factor …

NGLY1: a fascinating, multifunctional molecule

T Suzuki, H Fujihira - Biochimica et Biophysica Acta (BBA)-General …, 2024 - Elsevier
NGLY1, a cytoplasmic de-N-glycosylating enzyme is well conserved among eukaryotes.
This enzyme has attracted considerable attention after mutations on the NGLY1 gene were …

NGLY1 mutations cause protein aggregation in human neurons

A Manole, T Wong, A Rhee, S Novak, SM Chin… - Cell reports, 2023 - cell.com
Biallelic mutations in the gene that encodes the enzyme N-glycanase 1 (NGLY1) cause a
rare disease with multi-symptomatic features including developmental delay, intellectual …

An in vivo drug repurposing screen and transcriptional analyses reveals the serotonin pathway and GSK3 as major therapeutic targets for NGLY1 deficiency

KA Hope, AR Berman, RT Peterson, CY Chow - PLoS Genetics, 2022 - journals.plos.org
NGLY1 deficiency, a rare disease with no effective treatment, is caused by autosomal
recessive, loss-of-function mutations in the N-glycanase 1 (NGLY1) gene and is …

[HTML][HTML] Generation and characterization of NGLY1 patient-derived midbrain organoids

J Abbott, M Tambe, I Pavlinov, A Farkhondeh… - Frontiers in Cell and …, 2023 - frontiersin.org
NGLY1 deficiency is an ultra-rare, autosomal recessive genetic disease caused by
mutations in the NGLY1 gene encoding N-glycanase 1 that removes N-linked glycans …

The biogenesis of potassium transporters: implications of disease-associated mutations

M Kok, JL Brodsky - Critical Reviews in Biochemistry and Molecular …, 2024 - Taylor & Francis
The concentration of intracellular and extracellular potassium is tightly regulated due to the
action of various ion transporters, channels, and pumps, which reside primarily in the kidney …

Reversibility of motor dysfunction in the rat model of NGLY1 deficiency

M Asahina, R Fujinawa, H Hirayama, R Tozawa, Y Kajii… - Molecular brain, 2021 - Springer
Abstract N-glycanase 1 (NGLY1) deficiency is a rare inherited disorder characterized by
developmental delay, hypolacrima or alacrima, seizure, intellectual disability, motor deficits …

Evolutionary rate covariation identifies SLC30A9 (ZnT9) as a mitochondrial zinc transporter

A Kowalczyk, O Gbadamosi, K Kolor, J Sosa… - Biochemical …, 2021 - portlandpress.com
Recent advances in genome sequencing have led to the identification of new ion and
metabolite transporters, many of which have not been characterized. Due to the variety of …